Welcome to LookChem.com Sign In|Join Free

CAS

  • or

139626-20-3

Benzenamine, 2-chloro-4-fluoro-5-nitro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

139626-20-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 139626-20-3 Structure

  • Basic information

    1. Product Name: Benzenamine, 2-chloro-4-fluoro-5-nitro-
    2. Synonyms:
    3. CAS NO:139626-20-3
    4. Molecular Formula: C6H4ClFN2O2
    5. Molecular Weight: 190.561
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 139626-20-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Benzenamine, 2-chloro-4-fluoro-5-nitro-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Benzenamine, 2-chloro-4-fluoro-5-nitro-(139626-20-3)
    11. EPA Substance Registry System: Benzenamine, 2-chloro-4-fluoro-5-nitro-(139626-20-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 139626-20-3(Hazardous Substances Data)

139626-20-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 139626-20-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,6,2 and 6 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 139626-20:
(8*1)+(7*3)+(6*9)+(5*6)+(4*2)+(3*6)+(2*2)+(1*0)=143
143 % 10 = 3
So 139626-20-3 is a valid CAS Registry Number.

139626-20-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-4-fluoro-5-nitroaniline

1.2 Other means of identification

Product number -
Other names Benzenamine,2-chloro-4-fluoro-5-nitro

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:139626-20-3 SDS

139626-20-3Upstream product

139626-20-3Relevant articles and documents

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

-

Paragraph 00205; 00206, (2017/05/02)

The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.

HETEROARYL COMPOUNDS FOR KINASE INHIBITION

-

Paragraph 446, (2015/12/30)

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFRand mutant HER2 activity, are described herein.

KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

-

Page/Page column 92, (2008/06/13)

The present invention relates to novel kinase inhibitors and modulator compounds useful for the treatment of various diseases. More particularly, the invention is concerned with such compounds, kinase/compound adducts, methods of treating diseases, and methods of synthesis of the compounds. Preferrably, the compounds are useful for the modulation of kinase activity of Raf kinases and disease polymorphs thereof. Compounds of the present invention find utility in the treatment of mammalian cancers and especially human cancers including but not limited to malignant melanoma, colorectal cancer, ovarian cancer, papillary thyroid carcinoma, non small cell lung cancer, and mesothelioma. Compounds of the present invention also find utility in the treatment of rheumatoid arthritis and retinopathies including diabetic retinal neuropathy and macular degeneration.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 139626-20-3